Satsuma Prescription drugs Proclaims Optimistic Outcomes from the Ongoing STS101 ASCEND Part 3 Open-label, Lengthy-term Security Trial

[ad_1] STS101 demonstrated a positive security and tolerability profile, in step with medical expertise to this point Over 8,000 migraine assaults handled with greater than 10,000 doses of STS101; of which, over 5,500 migraine assaults handled with greater than 6,900 doses of STS101Mok2, the investigational product incorporating the improved, second-generation nasal supply gadget … Read more